Back to search results

Long COVID-19 Wearable Device Study

This study is looking at how wearable devices and special educational materials might help people manage symptoms of Long COVID, ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome), and POTS (Postural Orthostatic Tachycardia Syndrome). You could join if you are at least 18 years old and have one of these diagnoses. The study wants to see if using a wearable device and getting enhanced education can improve how severe your symptoms are, especially post-exertional malaise (when symptoms get worse after activity). Researchers will compare people who get a wearable device and enhanced education right away to those who get general information first. The goal is to understand these conditions better and see if these tools can help you feel better over 3 to 12 months.

Study design
This is an interventional study with a planned enrollment of 100,500 participants. It involves two groups, one of which will receive a wearable device and enhanced education.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will assess symptom severity at 3 months and collect data for 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05741112

The Long COVID-19 Wearable Device Study

Recruiting
NAAges 18+InterventionalBasic science
Scripps Translational Science Institute
~100,500 participants
Updated 2025-05-11 on ClinicalTrials.gov
What's tested:Wearable device

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses.
Measured over 3 months
+1 more outcome measured

Conditions

Long COVID
Postural Orthostatic Tachycardia Syndrome
Dysautonomia
Myalgic Encephalomyelitis
Chronic Fatigue Syndrome
Long Covid19

Explore related trials

Chronic Fatigue SyndromeDysautonomiaPost-Acute Sequelae of COVID-19Postural Orthostatic Tachycardia Syndrome

Where it's being run

1 sites across 1 states
California1

Who to contact

Andrea Goosen
[email protected]
0000000000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Is at least 18 years old.
Has a self/and or physician diagnosis of:
Long COVID (based on the WHO working definition),
ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
POTS (Postural Orthostatic Tachycardia Syndrome).
Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
Agrees to complete at least 75% of the study surveys.

Exclusion

As long as they meet inclusion there is no exclusion

What this trial measures

  • Primary Objective 1:Assess the effect of study-provided devices and enhanced educational materials to manage Long COVID-19 symptom severity, compared to general educational materials alone using data from participants survey responses.3 months

    Will measure relapse symptom frequency, symptom severity, pain, quality of life and overall health through the analysis and measurement of change in the weekly survey responses.

  • Primary Objective 2: Collate a unique longitudinal dataset combining patients' demographics, symptoms, symptom severity, quality of life, and sensor data including sleep, activity, heart rate, heart rate variability, and Body Battery.12 months

    Will measure relapse symptom frequency, symptom severity, pain, quality of life and overall health through the analysis and measurement of change from the baseline survey to the quarterly survey.